Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LONP1 | P36776 | 6/20 | 0.56 |
| ▸ | PSMB10 | P40306 | 3/20 | 0.56 |
| ▸ | PSMB2 | P49721 | 3/20 | 0.56 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.56 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.56 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.56 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.56 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.56 |
| ▸ | PSMA3 | P25788 | 2/20 | 0.56 |
| ▸ | PSMA4 | P25789 | 2/20 | 0.56 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.56 |
| ▸ | PSMB9 | P28065 | 2/20 | 0.56 |
| ▸ | PSMA5 | P28066 | 2/20 | 0.56 |
| ▸ | PSMB4 | P28070 | 2/20 | 0.56 |
| ▸ | PSMB6 | P28072 | 2/20 | 0.56 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.56 |
| ▸ | PSMB3 | P49720 | 2/20 | 0.56 |
| ▸ | PSMA6 | P60900 | 2/20 | 0.56 |
| ▸ | PSMA8 | Q8TAA3 | 2/20 | 0.56 |
| ▸ | PSMB7 | Q99436 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6850092 | 0.96 | LONP1 (0.54) | LONP1PSMB10PSMB2PSMB11PSMA7 | |
| SCHEMBL6850382 | 0.91 | LONP1 (0.57) | LONP1PSMB10PSMB2PSMB11PSMA7 | |
| SCHEMBL6850311 | 0.90 | LONP1 (0.56) | LONP1PSMB10PSMB2PSMB11PSMA7 | |
| SCHEMBL6848918 | 0.90 | LONP1 (0.56) | LONP1PSMB10PSMB2PSMB11PSMA7 | |
| SCHEMBL6850421 | 0.89 | LONP1 (0.56) | LONP1PSMB10PSMB2PSMB11PSMA7 | |
| SCHEMBL6850431 | 0.89 | LONP1 (0.56) | LONP1PSMB10PSMB2PSMB11PSMA7 | |
| SCHEMBL6848902 | 0.89 | LONP1 (0.56) | LONP1PSMB10PSMB2PSMB11PSMA7 | |
| SCHEMBL6851522 | 0.89 | LONP1 (0.56) | LONP1PSMB10PSMB2PSMB11PSMA7 | |
| SCHEMBL6850320 | 0.89 | LONP1 (0.62) | LONP1PSMB10PSMB2PSMB11PSMA7 | |
| SCHEMBL6849892 | 0.88 | LONP1 (0.58) | LONP1PSMB10PSMB2PSMB11PSMA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020123468-A1 | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-09-05 | — | — | US | claimed |
| US-6774212-B2 | FOR THERAPY OF VIRAL INFECTION OR AS AN ASSAY STANDARD OR REAGENT | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2004-08-10 | — | — | US | disclosed |
| US-20020123468-A1 | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020123468-A1 | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease | CES1, CYP51A1, SPINT2 | LONP1 250/4885PSMB10 691/4885PSMB2 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.